We now know that microbial communities, especially in our guts, profoundly affect immune response
Nov. 22, 2017
| By Sabin Russell / Fred Hutch News Service
Scientists at Fred Hutch are studying how the microbiome alters the immune system’s response to vaccines. Their work is already providing new insights on interactions between microbes in the body and the immune system that have implications for improving many types of vaccines.
A new algorithm created by Dr. Philip Bradley and colleagues could aid the development of tools to decode T-cell receptor sequences and, ultimately, improve the diagnosis and treatment of cancers, reported this week in Nature.
Gains in cancer survival at risk due to surge in multi-drug resistant superbugs
May 4, 2017
| By Mary Engel / Fred Hutch News Service
Antibiotics and other antimicrobials are unique among medications, a “shared resource” that we need to preserve, much as we steward our environment and natural resources, says Fred Hutch clinician-infectious disease researcher Dr. Catherine Liu. Overuse or misuse can lead to drug-resistant bugs that can then spread to new hosts and in some cases even spread their resistance genes to different microorganisms, posing a risk to society at large.
Dr. Larry Corey wins $2.6 million grant to explore using CAR T cells for HIV cure; Immune responses against virus-related cancer may provide clues for improved immunotherapy; Hutch/UW symposium underscores Seattle's reputation as "infectious disease central"; Fred Hutch CIO Matthew Trunnell among speakers at SLU Collaborative seminar.